ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 41.4 | 14.0 | 19.0 |
| Other income | 12.5 | 3.1 | 2.8 |
| Total income | 53.9 | 17.1 | 21.8 |
| Profit before exceptional items & tax | 0.6 | -0.8 | 6.9 |
| Exceptional items | 3.1 | 0.0 | 6.7 |
| Profit before tax | -2.5 | -1.9 | 0.2 |
| Net profit | -3.2 | -4.1 | -2.6 |
| Operating margin | -4.6% | -11.1% | 0.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +117.90% |
|---|
BSE results filing, NSE: PVP. Figures extracted from the filing.
PVP Ventures Ltd: key numbers
- Share price
- ₹49.69
- Market cap
- ₹1,294 Cr
- Revenue (annual)
- ₹89.71 Cr
- Net profit (annual)
- ₹-6.80 Cr
- P/E (TTM)
- 259.0×Sector 38.0×
- Promoter holding
- 61.30%+0.00% QoQ
- FII holding
- 0.81%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PVP Ventures Ltd
All →PVP Ventures Board Meeting Date
PVP Ventures intimated a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. The trading window stays closed until 48 hours after the results are declared.
PVP Ventures Bags ₹142.2 Cr Order from Elekta Solutions AB
PVP Ventures won a ₹142.15 Crore order from Sweden's Elekta Solutions AB for 10 HARMONY LINAC systems. Phased delivery is expected by October 2028.
- Value
- ₹142.2 Cr
- From
- Elekta Solutions AB
- Execution
- Phased delivery of 5+5 units, tentatively by October 2028
- medical linear accelerator units
- 10 LINAC systems
PVP Ventures Business Update
Evervie Health Limited signed an LOI to procure 10 LINAC systems from Elekta Solutions AB, valued at approximately $11–15 million (₹104.5–142.5 Crore).
- Value
- ₹104.5 Cr
- LINAC systems
- 10.0 units
PVP Ventures Other Announcement
Everyvie Health (formerly PVP Ventures) filed its Reg 76 share capital reconciliation report for Q2 FY27. No transaction or capital change is reported for the quarter.
PVP Ventures Debt & Borrowing: ₹13.46 Cr
Evervie Health Limited made an advance interest payment of ₹13.46 Crore on its Non-Convertible Debentures, fulfilling its debt obligations for future scheduled payment dates.
- Value
- ₹13.46 Cr
PVP Ventures Annual Report
Evervie Health Limited submitted an updated Annual Report for FY 2025-26. This filing incorporates an addendum and corrigendum to the previously submitted report.